Summary:
In this study, adult male C57BL/6J mice were fed normal chow and exposed to daylight sleep fragmentation (SF) or control sleep (CTL) for 20 weeks. During the post-occlusive period, SF-exposed mice exhibited increased latencies to reach baseline perfusion levels and increased systemic BP values first seen at 8 weeks of SF persisted thereafter. Examination of excised aortas from SF-exposed mice failed to reveal any obvious atherosclerotic plaques, but there was evidence of marked elastic fibre disruption and fibre disorganisation, as well as increased numbers of foam cells and macrophages in the aorta wall. Senescence markers showed reduced TERT and cyclin A and increased p16INK4a expression, with higher interleukin-6 plasma levels in SF-exposed mice.
Comment: Pathogenesis of the cardiovascular morbidities and attached mortality of OSA has been linked to repetitive hypoxic insults and their sequelae. It has been somewhat unclear, however, as to whether sleep fragmentation (SF) and associate arousals has an important separate contribution to that CV morbidity-mortality burden of OSA apart from hypoxia-driven consequences. This study provides basic support in an animal model to the notion that the fragmentation-arousals nexus of itself has important CV morbidity consequences in OSA at the endothelial level and on systemic BP, and may help to refocus efforts to consider interventions that address not just obstructions-hypoxia but also the other common feature of SF in sleep disorders, such as occurs in but is not limited to OSA. This work may also help to clarify our thinking more specifically about SF-arousal predominant OSA not characterised by significant hypoxaemia.
Reference: Sleep. 2014;37(11):1817-24 Abstract
Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates Authors: Kauta SR et al.
Summary: This study involved 106 patients who reported symptoms consistent with sleepdisordered breathing (SDB) while being hospitalised for heart failure, arrhythmias, and myocardial infarction. Portable monitoring systems yielded conclusive diagnostic studies for 104 patients, 81 (78%) of whom had SDB (AHI ≥5 events/h). Sixty-five (80%) of the 81 patients had predominantly OSA, while 16 (20%) had predominantly central sleep apnoea. Positive airway pressure (PAP) treatment was initiated in the 81 patients diagnosed with sleep apnoea. Adequate adherence to treatment was defined as using PAP therapy ≥4 hours per night on ≥70% of nights. None of 19 patients with adequate PAP adherence, 6 of 20 (30%) with partial PAP use, and 5 of 17 (29%) of patients who did not use PAP were readmitted to the hospital or visited the emergency department for a cardiac issue within 30 days from discharge (p=0.025).
Comment: There is a very high prevalence of OSA in heart failure patients, and in cardiac patients more generally. Cardiovascular morbidity is an identified adverse outcome of untreated OSA, and OSA itself is highly prevalent. It is not surprising that OSA contributes to hospitalisation of heart failure patients, and to readmission rates. This study demonstrates a significant advantage in terms of reduced readmission rates to those cardiac patients who, during an acute admission, are diagnosed with OSA (using an unattended portable monitoring [type III in this instance] device) and initiated treatment with auto-CPAP. While there are limitations to this study, this result, if replicated in other health care systems, is advantageous not only potentially for individual patients but also for those concerned with the financing of acute hospital care.
Reference: J Clin Sleep Med. 2014;10(10):1051-9 Abstract
Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea Authors: Sands SA et al.
Summary:
This study compared key physiological traits (upper airway anatomy/ collapsibility, upper airway muscle responsiveness, ventilator stability, arousability from sleep) among overweight/obese individuals (body mass index >25 kg/m 2 ) who either did have OSA (AHI ≥15 events/h; n=25) or did not (AHI <15 events/h; n=18) and among normal-weight patients without apnoea (controls; n=11). Overweight/obese subjects without apnoea exhibited a less collapsible airway than overweight/obese patients with apnoea (mean critical closing pressure -3.7 vs 0.6 cm H 2 O; p=0.003), but a more collapsible airway relative to normal-weight controls (-8.8 cm H 2 O; p<0.001). Notably, overweight/obese subjects without apnoea exhibited a three-fold greater upperairway muscle responsiveness than both overweight/obese patients with apnoea (mean Δgenioglossus EMG/Δepiglottic pressure -0.49 vs -0.15 %max/cm H 2 O; p=0.008) and normal-weight controls (-0.16 %max/cm H 2 O; p=0.02). Loop gain was elevated (more negative) in both overweight/obese groups and normal-weight controls (p=0.02). Model-based analysis demonstrated that overweight/obese individuals without apnoea rely on both more favourable anatomy and collapsibility and enhanced upper-airway dilator muscle responses to avoid OSA.
Comment: As we approach the era of personalised medicine, a more sophisticated analysis of the relevant physiological traits that contribute to upper airway obstruction in OSA potentially provides opportunities of different treatment options beyond, although not necessarily relegating, CPAP. The authors of this study continue exploring the key physiological variables (upper airway collapsibility, neuromuscular compensatory response to collapse, ventilatory stability, and sleep maintenance) employed in other recent work and apply that analytical approach to the clinical cohort of the "non-apnoeic" (AHI <15/hr) overweight/obese. From this novel approach is described a 3-fold enhancement of neuromuscular compensative drive by the non-apnoeic overweight/obese, combined with an UA anatomy that is only moderately adverse cf their apnoeic overweight/obese confreres. This approach may offer, at least in principle, pathways to tailor specific non-CPAP treatments to particular OSA phenotypes.
Reference: Am J Respir Crit Care Med. 2014; 190(8):930-7 Abstract Optogenetic stimulation of adrenergic C1 neurons causes sleep state-dependent cardiorespiratory stimulation and arousal with sighs in rats Authors: Burke PG et al.
Outcomes are reported from the simultaneous optogenetic stimulation of sympathoexcitatory, hypoxia-responsive C1 neurons and central respiratory chemoreceptors (retrotrapezoid nucleus, RTN) located in the rostral ventrolateral medulla (RVLM) of tyrosine hydroxylase (TH)-Cre rats. The researchers injected a Cre-dependent vector expressing channelrhodopsin 2 (ChR2) fused with enhanced yellow fluorescent protein or mCherry into the RVLM of these animals and examined the response of ChR2-transduced neurons to light in anesthetised rats. The vast majority (95%) of ChR2-expressing neurons contained C1 neuron markers and innervated the spinal cord. RTN neurons were not transduced. During anaesthesia, C1 cells were activated by each light pulse up to 40 Hz. During quiet resting and non-REM sleep, C1 cell stimulation (20 s, 2-20 Hz) increased BP and respiratory frequency and produced sighs and arousal from non-REM sleep. Arousal was frequency-dependent (85% probability at 20 Hz). Stimulation during REM sleep increased BP, but did not affect EEG or breathing. C1 cell-mediated breathing stimulation was occluded by hypoxia (12% FI O2 ), but was unchanged by 6% FI CO2 .
Comment: Optogenetics is a relatively new and precise neuromodulation method that allows for in vivo exploration of the effects of stimulation of specific neurons or groups of neurons with similar characteristics. The authors of this study apply optogenetics methodology to the study of the brainstem of rodents, specifically the C1 neurons of the RVLM, which have previously been implicated, along with other associated non-C1 RVLM neurons, in arousal from sleep, along with breathing stimulation, a rise in BP, and sighs. The study confirmed that selective activation, specifically in non-REM sleep, of the C1 neurons increases breathing as well as BP and faithfully produces sighs and arousal from non-REM sleep, thereby reproducing most of the effects of hypoxia. While this exquisite approach helps to micro-dissect basic pathophysiological pathways in apnoea-related hypoxia, it remains unclear at this stage as to whether any potentially therapeutic inferences can be deduced.
